Pictet Asset Management
XERS icon

Pictet Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Pictet Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Hold
29,999
– – ﹤0.01% 1895
2026
Q1 		$174K Buy
29,999
+6,803
+29% +$45.1K ﹤0.01% 1963
2025
Q4 		$182K Hold
23,196
– – ﹤0.01% 1945
2025
Q3 		$189K Buy
+23,196
New +$154K ﹤0.01% 1895

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Pictet Asset Management's XERS Position: Q2 2026 in Review

Pictet Asset Management held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 29,999 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Pictet Asset Management first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. 85 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Pictet Asset Management held 29,999 shares of Xeris Biopharma Holdings worth $238K as of Q2 2026.
  • Pictet Asset Management left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1895 holding.
  • Pictet Asset Management first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • 85 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.